These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18026710)

  • 1. [The neuroleptic treatment of delusional parasitosis: first experiences with aripiprazole].
    Kumbier E; Höppner J
    Hautarzt; 2008 Sep; 59(9):728-30, 732-3. PubMed ID: 18026710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in the treatment of primary delusional parasitosis.
    Narayan V; Ashfaq M; Haddad PM
    Br J Psychiatry; 2008 Sep; 193(3):258; author reply. PubMed ID: 18757994
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole in the treatment of delusional parasitosis with ocular and dermatologic presentations.
    Huang WL; Chang LR
    J Clin Psychopharmacol; 2013 Apr; 33(2):272-3. PubMed ID: 23422386
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic treatment of primary delusional parasitosis: systematic review.
    Lepping P; Russell I; Freudenmann RW
    Br J Psychiatry; 2007 Sep; 191():198-205. PubMed ID: 17766758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
    Ziegenbein M; Sieberer M; Calliess IT; Kropp S
    Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia.
    Pondé MP; Novaes CM
    Braz J Psychiatry; 2007 Mar; 29(1):92. PubMed ID: 17435943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delusional parasitosis: case report].
    Jakuszkowiak-Wojten K; Cubała WJ; Szeliga-Lewińska J
    Psychiatr Pol; 2007; 41(4):571-8. PubMed ID: 18046987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics in the treatment of delusional parasitosis.
    Wenning MT; Davy LE; Catalano G; Catalano MC
    Ann Clin Psychiatry; 2003; 15(3-4):233-9. PubMed ID: 14971869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole-induced agitation after clozapine discontinuation: a case report.
    Cho DY; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):141-3. PubMed ID: 19222986
    [No Abstract]   [Full Text] [Related]  

  • 11. Aripiprazole and the neuroleptic malignant syndrome.
    Strawn JR
    Schizophr Res; 2006 Jul; 85(1-3):298-9. PubMed ID: 16678389
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
    Pigato G; Toffanin T; Perini GI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):153-5. PubMed ID: 18801403
    [No Abstract]   [Full Text] [Related]  

  • 14. Complex visual hallucinations and delusional infestation comorbidity.
    Rocha FL; Caramelli P; Oliveira LC
    Arq Neuropsiquiatr; 2012 Jul; 70(7):553-4. PubMed ID: 22836466
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting injectable antipsychotics: an underutilized treatment option.
    Heres S
    J Clin Psychiatry; 2014 Nov; 75(11):1263-5. PubMed ID: 25470087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee JH; Lee YH; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2009; 32(5):243-9. PubMed ID: 19620849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.
    Saatcioglu O; Gumus S; Kamberyan K; Yanik M
    Psychopharmacol Bull; 2010; 43(4):70-2. PubMed ID: 21240152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delusional parasitosis and the matchbox sign revisited: the international perspective.
    Freudenmann RW; Kölle M; Schönfeldt-Lecuona C; Dieckmann S; Harth W; Lepping P
    Acta Derm Venereol; 2010 Sep; 90(5):517-9. PubMed ID: 20814630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.